Octapharma Announces $1.5B US Manufacturing Facility in Rock Hill, SC

Octapharma plans a $1.5 billion facility in South Carolina to produce critical plasma-based therapies domestically.

Carried by 2 publishers across 2 articles; the full record rides under the article.

TruthFoundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.